BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 28033217)

  • 1. Measuring Glucose Uptake in Primary Invasive Breast Cancer Using Simultaneous Time-of-Flight Breast PET/MRI: A Method Comparison Study with Prone PET/CT.
    Fowler AM; Kumar M; Bancroft LH; Salem K; Johnson JM; Karow J; Perlman SB; Bradshaw TJ; Hurley SA; McMillan AB; Strigel RM
    Radiol Imaging Cancer; 2021 Jan; 3(1):e200091. PubMed ID: 33575660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of myogenic stem/progenitor cells with [
    Wargocka-Matuszewska W; Fiedorowicz K; Rugowska A; Bednarowicz K; Zimna A; Cheda Ł; Hamankiewicz P; Kilian K; Fiedorowicz M; Drabik M; Rozwadowska N; Rogulski Z; Kurpisz M
    Sci Rep; 2021 Oct; 11(1):19825. PubMed ID: 34615887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Renal Failure on F18-FDG PET/CT Scans.
    Kode V; Karsch H; Osman MM; Muzaffar R
    Front Oncol; 2017; 7():155. PubMed ID: 28785537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
    Mistry V; Scott JR; Wang TY; Mollee P; Miles KA; Law WP; Hapgood G
    Cancer Imaging; 2023 Jan; 23(1):11. PubMed ID: 36694244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition.
    Graef J; Senger C; Wetz C; Baur ADJ; Kluge AK; Lukas M; Rogasch JMM; Walter-Rittel TC; Kohnert D; Makowski M; Acker G; Huang K; Budach V; Amthauer H; Schatka I; Furth C
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUV
    Wang C; Zhao K; Hu S; Huang Y; Ma L; Li M; Song Y
    Front Oncol; 2020; 10():1630. PubMed ID: 33014819
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective comparison of
    Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
    Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
    Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
    Kirchner J; Sawicki LM; Suntharalingam S; Grueneisen J; Ruhlmann V; Aktas B; Deuschl C; Herrmann K; Antoch G; Forsting M; Umutlu L
    PLoS One; 2017; 12(2):e0172553. PubMed ID: 28225831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
    Paquet N; Albert A; Foidart J; Hustinx R
    J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.
    Spick C; Herrmann K; Czernin J
    J Nucl Med; 2016 Mar; 57(3):420-30. PubMed ID: 26742709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.
    Aide N; Lasnon C; Veit-Haibach P; Sera T; Sattler B; Boellaard R
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):17-31. PubMed ID: 28623376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of 18F-FDG PET Uptake in Tumor and Normal Tissues on PET/MRI and PET/CT.
    Law WP; Maggacis N; Jeavons SJ; Miles KA
    Clin Nucl Med; 2017 Mar; 42(3):180-186. PubMed ID: 28033217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/MRI in a Tertiary Pediatric Hospital: A Prospective Study.
    Lyons K; Seghers V; Sorensen JI; Zhang W; Paldino MJ; Krishnamurthy R; Rohren EM
    AJR Am J Roentgenol; 2015 Nov; 205(5):1094-101. PubMed ID: 26496558
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.